CagriSema is a combination research blend of Cagrilintide (5mg) and Semaglutide (5mg), two complementary metabolic peptides. Cagrilintide is a long-acting amylin analogue while Semaglutide is a GLP-1 receptor agonist. Together they are studied for synergistic effects on appetite suppression, weight management, and glycemic control. Each kit contains 10 vials for research use.
Weight ManagementCagriSema — Cagrilintide 5mg + Semaglutide 5mg x 10Weight Management
CagriSema — Cagrilintide 5mg + Semaglutide 5mg x 10
$564.00
CagriSema is a combination research blend of Cagrilintide (5mg) and Semaglutide (5mg), two complementary metabolic peptides. Cagrilintide is a long-acting amylin analogue while Semaglutide is a GLP-1 receptor agonist. Together they are studied for synergistic effects on appetite suppression, weight management, and glycemic control. Each kit contains 10 vials for research use.

